Podcast: Maximizing The UK Medtech Opportunity In Times Of Change
Device access consultant advises how medtechs can improve their market access potential
“Sell the problem your technology can solve,” Michael Branagan-Harris, CEO of Device Access UK Consultancy, advises medtech companies targeting a launch on the UK market. In this podcast with Medtech Insight, he explains how companies with awareness should grasp the new opportunities soon to be available following changes to device access and regulation in Great Britain.
You may also be interested in...
Connecting The Dots Between Diversity, Empowerment And Business Growth
Urmi Prasad Richardson brings a wealth of science and business experience to diagnostics and life sciences multinational Thermo Fisher Scientific, where for the past two years she has been president of the group’s vast and varied EMEA business. The Indian-born, Germany-based executive has surmounted a range of challenges along the way and offers her story as inspiration for others.
UK LifeSci Funding Boost – Medtech Research And Regulation To Benefit
Rebranded Health Innovation Networks, Biobanks and clinical trials get share of £650m UK funding earmarked to support research, manufacturing, skills development and access to diagnosis and treatment.
UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment
Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.